[Michael Self 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP £ (a) £ (b) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0]
[2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER (1) 6 SHARED VOTING POWER 7 SOLE DISPOSITIVE POWER (1) 8 SHARED DISPOSITIVE POWER 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH 74,403,234 ordinary shares]
[Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho Senior Vice President & Chief Financial Officer TSMC January 2012 Sales Report Hsinchu, Taiwan, R.O.C. February 10, 2012 - On a consolidated basis, net sales for January 2012 were approximately NT$ 34.57 billion, an increase of 10.6 percent over December 2011 and a decrease of 2.3 percent over January 2011.]
[Yuncai Wu (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) S (b) £ (3) SEC USE ONLY (4) CITIZENSHIP OR PLACE OF ORGANIZATION People’s Republic of China NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH (5) SOLE VOTING POWER 5,684,195 Shares (6) SHARED VOTING POWER 4,820,775 Shares (consisting of 4,820,775 shares beneficially owned by]
[SCHEDULE 13G (Amendment No. 3)* WuXi PharmaTech (Cayman) Inc. (Name of Issuer) Ordinary Shares, par value $0.02 per share (Title of Class of Securities) 929352102 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) o Rule 13d-1(b) o Rule 13d-1(c) x Rule 13d-1(d) *The remainder of this cover page shall be filled out for a]
[2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER (1) 6 SHARED VOTING POWER 7 SOLE DISPOSITIVE POWER (1) 8 SHARED DISPOSITIVE POWER 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH 74,403,234 ordinary shares]
[Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho Senior Vice President & Chief Financial Officer TSMC January 2012 Sales Report Hsinchu, Taiwan, R.O.C. February 10, 2012 - On a consolidated basis, net sales for January 2012 were approximately NT$ 34.57 billion, an increase of 10.6 percent over December 2011 and a decrease of 2.3 percent over January 2011.]
[Yuncai Wu (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) S (b) £ (3) SEC USE ONLY (4) CITIZENSHIP OR PLACE OF ORGANIZATION People’s Republic of China NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH (5) SOLE VOTING POWER 5,684,195 Shares (6) SHARED VOTING POWER 4,820,775 Shares (consisting of 4,820,775 shares beneficially owned by]
[SCHEDULE 13G (Amendment No. 3)* WuXi PharmaTech (Cayman) Inc. (Name of Issuer) Ordinary Shares, par value $0.02 per share (Title of Class of Securities) 929352102 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) o Rule 13d-1(b) o Rule 13d-1(c) x Rule 13d-1(d) *The remainder of this cover page shall be filled out for a]
[1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Capital World Investors ** 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware 5 SOLE VOTING POWER 2,896,625 6 SHARED VOTING POWER NUMBER OF SHARES NONE BENEFICIALL Y OWNED BY]
